Evidence map›Paper›PMID 31227998›Full record

ReviewCurrent osteoporosis reports2019

Investigating Osteocytic Perilacunar/Canalicular Remodeling.

Cristal S Yee, Charles A Schurman, Carter R White, Tamara Alliston

Open access · greenAbstract readReview
In one paragraph

Review in Current osteoporosis reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Consequences of Aging on Bone.Aging and disease · 2023
    Pooled it
  2. Review
  3. Bone Fragility: Time to Address the Matrix.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2026
    Article
  4. Article
  5. Review
  6. Alzheimer's Disease Risk Factor APOE4 Exerts Dimorphic Effects on Female Bone.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Drug delivery for age-related bone diseases: From therapeutic targets to common and emerging therapeutic strategies.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Cristal S YeeDepartment of Orthopaedic Surgery, University of California, 513 Parnassus Avenue, San Francisco, CA, 94143, USA.
Charles A SchurmanDepartment of Orthopaedic Surgery, University of California, 513 Parnassus Avenue, San Francisco, CA, 94143, USA.
Carter R WhiteDepartment of Orthopaedic Surgery, University of California, 513 Parnassus Avenue, San Francisco, CA, 94143, USA.
Tamara AllistonDepartment of Orthopaedic Surgery, University of California, 513 Parnassus Avenue, San Francisco, CA, 94143, USA. tamara.alliston@ucsf.edu.
University of California, Berkeley · USUniversity of California, San Francisco · US

Funding

The mechanistic control of bone quality and joint crosstalk by osteocytesR01DE019284 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HERNANDEZ, CHRISTOPHER JOHN · 2009 to 2024
$7.6M
Skeletal Biology and Biomechanics (SBB) CoreP30AR075055 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Wenhan Chang · 2019 to 2026
$7.1M
UCSF Core Center for Musculoskeletal Biology and MedicineP30AR066262 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LOTZ, JEFFREY C. · 2014 to 2018
$3.0M
miRNA coordination of TGF-beta / Wnt signaling in osteocyte mechanotransductionR21AR070403 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ALLISTON, TAMARA N · 2017 to 2018
$384k
NIAMS NIH HHS P30 AR066262NIAMS NIH HHS P30 AR075055NIAMS NIH HHS R21 AR070403NIDCR NIH HHS R01 DE019284
6 · The paper itself

Abstract

purpose of reviewIn perilacunar/canalicular remodeling (PLR), osteocytes dynamically resorb, and then replace, the organic and mineral components of the pericellular extracellular matrix. Given the enormous surface area of the osteocyte lacuna-canalicular network (LCN), PLR is important for maintaining homeostasis of the skeleton. The goal of this review is to examine the motivations and critical considerations for the analysis of PLR, in both in vitro and in vivo systems. RECENT

findingsMorphological approaches alone are insufficient to elucidate the complex mechanisms regulating PLR in the healthy skeleton and in disease. Understanding the role and regulation of PLR will require the incorporation of standardized PLR outcomes as a routine part of skeletal phenotyping, as well as the development of improved molecular and cellular outcomes. Current PLR outcomes assess PLR enzyme expression, the LCN, and bone matrix composition and organization, among others. Here, we discuss current PLR outcomes and how they have been applied to study PLR induction and suppression in vitro and in vivo. Given the role of PLR in skeletal health and disease, integrated analysis of PLR has potential to elucidate new mechanisms by which osteocytes participate in skeletal health and disease.

Indexed as

Bone MatrixBone RemodelingCarbonic AnhydrasesCathepsin KCell LineHomeostasisHumansHydrogen-Ion ConcentrationImaging, Three-DimensionalMatrix MetalloproteinasesMicroscopy, ConfocalMicroscopy, Electron, ScanningOsteocytesProton-Translocating ATPasesX-Ray MicrotomographyCarbonic AnhydrasesCathepsin KMatrix MetalloproteinasesProton-Translocating ATPasesLacuna-canalicular networkOsteocytePerilacunar/canalicular remodeling

Identifiers

PMID31227998
PMCPMC7202397
OpenAlexW2950949353

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.